Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients

Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients

The use of intravenous bisphosphonates (pamidronate or zoledronic acid) is the cornerstone for the management of multiple myeloma-(MM-) related bone disease. However, osteonecrosis of the jaw (ONJ) is a rare, but sometimes difficult to manage, adverse effect of bisphosphonates therapy. A retrospecti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pelagia I. Melea, Ioannis Melakopoulos, Efstathios Kastritis, Christina Tesseromatis, Vasileios Margaritis, Meletios A. Dimopoulos, Evangelos Terpos
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	International Journal of Dentistry
Online Access:	http://dx.doi.org/10.1155/2014/427273
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessment Results of Dental Students' Knowledge about Bisphosphonates and Bisphosphonate-Related Osteonecrosis of the Jaw
by: Greta Sereikaite, et al.
Published: (2023-12-01)

Knowledge of Brazilian dentists about bisphosphonate-associated osteonecrosis of the jaw
by: Thainara Alexia Marinho de Souza, et al.
Published: (2024-04-01)

Time since last intravenous bisphosphonate and risk of osteonecrosis of the jaw in osteoporotic patients
by: Jung-Hyun Park, et al.
Published: (2025-05-01)

Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats
by: Felipe M. Silveira, et al.
Published: (2017-01-01)

Concomitant Factors Leading to an Atypical Osteonecrosis of the Jaw in a Patient with Multiple Myeloma
by: Jaume Miranda-Rius, et al.
Published: (2014-01-01)

Experience of bisphosphonate related osteonecrosis of the jaw treatment in patient with chronic periodontitis of mandibular teeth (case review)
Published: (2020-04-01)

Management of Medication-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients With Pentoxifylline and Tocopherol: Case Reports
by: Adepitan A. Owosho, et al.
Published: (2025-01-01)

The Role of the Bone Marrow Microenvironment in Physical Function and Quality of Life in Patients with Multiple Myeloma After First-Line Treatment with Novel Agents and Autologous Transplantation
by: Polyxeni Spiliopoulou, et al.
Published: (2025-05-01)

Radiologic and Pathologic Insights into Medication-Related Osteonecrosis of the Jaw in Myeloma Patients: A Report of 3 Cases
by: Suvarna Indermun, BDS, PgDip, MSc, et al.
Published: (2025-10-01)

ONJ (MRONJ) Update 2024: Osteonecrosis of the Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment—A National Italian Symposium
by: Vittorio Fusco, et al.
Published: (2025-04-01)

Surgical treatment of osteonecrosis associated with bisphosphonates: a case report
by: Luisa Machado Barin, et al.
Published: (2017-09-01)

Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
by: Rial Seluki, et al.
Published: (2023-12-01)

Neuralgia Inducing Cavitational Osteonecrosis of the Jaw: Scientific Controversy or pseudoscience?
by: Keith DA
Published: (2025-08-01)

Use of ozone therapy together to low power laser in osteonecrosis induced bisphosphonates - Clinical case
by: Michelle Bianchi Moraes, et al.
Published: (2016-03-01)

Short-Term Bisphosphonate Therapy Could Ameliorate Osteonecrosis: A Complication in Childhood Hematologic Malignancies
by: N. A. Greggio, et al.
Published: (2010-01-01)

Denosumab-Induced Osteonecrosis of the Jaw with FDG PET/CT imaging features.
by: SALONI RAJKOTIA, et al.
Published: (2024-11-01)

Use of Platelet-Rich Fibrin for Jaw Osteonecrosis: A Case Report
by: Petya Kanazirska, et al.
Published: (2020-12-01)

Clinical Management of Suppurative Osteomyelitis, Bisphosphonate-Related Osteonecrosis, and Osteoradionecrosis: Report of Three Cases and Review of the Literature
by: Eduardo Pereira Guimarães, et al.
Published: (2013-01-01)

Platelet Rich Fibrin (PRF) in the Management of Osteonecrosis of the Jaw: A Narrative Review
by: A F M Shakilur Rahman
Published: (2025-04-01)

Research progress on the at-risk category and stage 0 of medication-related osteonecrosis of the jaw
by: YANG Mu, et al.
Published: (2025-02-01)

The Application and Validity of a New Composite Radiographic Index for Patients with Osteonecrosis of the Jaws
by: Zafeiroula Yfanti, et al.
Published: (2025-04-01)

Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population
by: Miika Kujanpää, et al.
Published: (2025-05-01)

Experimental study of the effect of teriparatide on a medication-related rat model of osteonecrosis of the jaw
by: LIAO Chenyu, et al.
Published: (2024-02-01)

Risk of Osteonecrosis of the Jaw in Patients Treated with Zoledronic or Alendronic Acid: A Systematic Review
by: Aine Jakonyte, et al.
Published: (2025-06-01)

Medication-Related Osteonecrosis of the Jaw: A Case Report of an Unusual Side Effect of Adalimumab
by: Laura Sisalli, et al.
Published: (2023-01-01)

Omega-3 attenuates the severity of medication-related osteonecrosis of the jaws in rats treated with zoledronate.
by: Juliano Milanezi de Almeida, et al.
Published: (2025-01-01)

Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study
by: Carlyn Rose Tan, et al.
Published: (2025-04-01)

Occlusive denture for the management of medication-related osteonecrosis of the jaw with oronasal communication: A case report
by: Arthur Augusto Martins e Silva, et al.
Published: (2025-06-01)

Vascularised periosteal free flap reconstruction for medication-related osteonecrosis of the jaw: a case series
by: Isabella Reid, et al.
Published: (2022-03-01)

Analysis of prosthetic risk factors for peri-implant medication-related osteonecrosis of the jaw: an observational study
by: Da Young Kim, et al.
Published: (2025-05-01)

Quantitative indices for cone-beam CT assessment of Medication-Related Osteonecrosis of the Jaw – a scoping review
by: Ghaidaa Badabaan, et al.
Published: (2023-02-01)

Surgical extraction with photobiomodulation as an adjunctive modality in patients at-risk for medication-related osteonecrosis of the jaw: retrospective study
by: Gianluca Tenore, et al.
Published: (2025-04-01)

Keeping an Eye on Bisphosphonate Therapy in Myeloma: A Case Report of Ocular Inflammation Postzoledronic Acid Infusion
by: Rehman Faryal, et al.
Published: (2021-01-01)

How does medication-related osteonecrosis of the jaw (MRONJ) influence the health-related quality of life after surgery?
by: Oliver Bissinger, et al.
Published: (2025-06-01)

The issue with incidence: a scoping review of reported medication-related osteonecrosis of the jaws (MRONJ) incidence around the globe
by: Anne-Marie Glenny, et al.
Published: (2025-05-01)

Treatment of Medication-Related Osteonecrosis of the Jaw Without and With the Use of Advanced Platelet-Rich Fibrin: A Retrospective Clinical Study
by: Paulina Adamska, et al.
Published: (2025-05-01)

Endodontic therapy and Medication-related osteonecrosis of the jaw onset: a scoping review and expert opinion-based qualitative meta-synthesis
by: R. Mauceri, et al.
Published: (2025-08-01)

Case Report: Virtual surgery and 3D printing in a medication-related osteonecrosis of the jaws (MRONJ) pathological mandibular fracture
by: Giorgio Lo Giudice, et al.
Published: (2025-03-01)

Novel modified quantitative index for cone-beam CT assessment of medication-related osteonecrosis of the jaw - comparative analysis with original index
by: Ghaidaa Badabaan, et al.
Published: (2023-05-01)

CyTOF profiling of bone marrow immune dynamics across myeloma stages
by: Dana Cholujova, et al.
Published: (2025-12-01)